X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16909) 16909
Publication (1455) 1455
Newsletter (325) 325
Book Review (120) 120
Book Chapter (18) 18
Conference Proceeding (17) 17
Dissertation (4) 4
Magazine Article (4) 4
Newspaper Article (4) 4
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (10273) 10273
female (8439) 8439
male (7385) 7385
cyclophosphamide (7300) 7300
animals (6196) 6196
index medicus (5305) 5305
adult (4705) 4705
middle aged (4639) 4639
mice (4385) 4385
cyclophosphamide - therapeutic use (4367) 4367
immunology (3969) 3969
oncology (3791) 3791
hematology (3619) 3619
cyclophosphamide - administration & dosage (3463) 3463
cyclophosphamide - pharmacology (3463) 3463
transplantation (3003) 3003
aged (2827) 2827
treatment outcome (2473) 2473
chemotherapy (2272) 2272
antineoplastic combined chemotherapy protocols - therapeutic use (2190) 2190
cancer (2050) 2050
adolescent (2028) 2028
immunosuppressive agents - therapeutic use (1832) 1832
therapy (1568) 1568
rituximab (1502) 1502
care and treatment (1465) 1465
immunosuppression (1394) 1394
child (1341) 1341
time factors (1312) 1312
immunotherapy (1288) 1288
retrospective studies (1262) 1262
rheumatology (1261) 1261
prognosis (1217) 1217
research (1150) 1150
combined modality therapy (1133) 1133
cyclophosphamide - adverse effects (1130) 1130
t-lymphocytes - immunology (1086) 1086
transplantation, homologous (1084) 1084
drug therapy, combination (1035) 1035
rats (996) 996
analysis (989) 989
antineoplastic combined chemotherapy protocols - administration & dosage (982) 982
stem cells (981) 981
health aspects (965) 965
doxorubicin - administration & dosage (941) 941
mice, inbred balb c (928) 928
survival (912) 912
vincristine - administration & dosage (909) 909
follow-up studies (902) 902
mice, inbred c57bl (902) 902
prednisone - therapeutic use (881) 881
disease-free survival (853) 853
child, preschool (850) 850
bone-marrow-transplantation (833) 833
young adult (830) 830
bone marrow transplantation (827) 827
risk factors (827) 827
medicine & public health (817) 817
hematopoietic stem cells (811) 811
hematopoietic stem cell transplantation (800) 800
disease (795) 795
remission induction (778) 778
research article (775) 775
recurrence (767) 767
spleen - immunology (766) 766
prednisone - administration & dosage (762) 762
lymphomas (755) 755
leukemia (744) 744
survival analysis (729) 729
aged, 80 and over (711) 711
survival rate (709) 709
patients (706) 706
immunosuppressive agents - administration & dosage (687) 687
dose-response relationship, drug (672) 672
antineoplastic combined chemotherapy protocols - adverse effects (648) 648
lymphoma (644) 644
immunosuppressive agents - pharmacology (637) 637
systemic lupus erythematosus (634) 634
transplantation, autologous (629) 629
vincristine - therapeutic use (618) 618
t cells (615) 615
antineoplastic agents - therapeutic use (603) 603
bone marrow (594) 594
drug therapy (590) 590
surgery (588) 588
children (587) 587
stem-cell transplantation (587) 587
pharmacology & pharmacy (581) 581
diagnosis (580) 580
disease models, animal (578) 578
lymphocytes (569) 569
non-hodgkins-lymphoma (568) 568
transplantation conditioning - methods (565) 565
article (556) 556
doxorubicin - therapeutic use (543) 543
expression (540) 540
bone-marrow transplantation (530) 530
dosage and administration (521) 521
mortality (520) 520
antibodies (515) 515
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (16145) 16145
Russian (237) 237
German (234) 234
Japanese (178) 178
French (131) 131
Chinese (122) 122
Spanish (65) 65
Italian (52) 52
Polish (36) 36
Hungarian (15) 15
Czech (7) 7
Bulgarian (5) 5
Romanian (4) 4
Ukrainian (4) 4
Croatian (3) 3
Dutch (3) 3
Hebrew (3) 3
Portuguese (3) 3
Slovak (3) 3
Norwegian (2) 2
Korean (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2016, Volume 2016, Issue 10, p. CD002827
Journal Article
Immunity, ISSN 1074-7613, 10/2016, Volume 45, Issue 4, pp. 931 - 943
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 10/2012, Volume 209, Issue 11, pp. 2113 - 2126
Harnessing the adaptive immune response to treat malignancy is now a clinical reality. Several strategies are used to treat melanoma; however, very few result... 
OX40 | MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | TRANSCRIPTION FACTOR EOMESODERMIN | CYCLOPHOSPHAMIDE | FACILITATED ADOPTIVE IMMUNOTHERAPY | TUMOR | CANCER-IMMUNOTHERAPY | ANTITUMOR IMMUNITY | IMMUNOLOGY | LARGE ESTABLISHED MELANOMA | CUTTING EDGE | Cyclophosphamide - administration & dosage | Humans | T-Box Domain Proteins - immunology | Th2 Cells - immunology | Th1 Cells - immunology | Receptors, OX40 - immunology | CD4-Positive T-Lymphocytes - immunology | Th1 Cells - metabolism | Receptors, OX40 - metabolism | Melanoma, Experimental - immunology | RNA Interference | Antigens, Neoplasm - metabolism | Membrane Proteins - metabolism | Cytotoxicity, Immunologic - drug effects | Immunologic Memory - immunology | Cytokines - immunology | Cytokines - metabolism | Immunotherapy, Adoptive | Oxidoreductases - metabolism | Antigens, Neoplasm - immunology | Oxidoreductases - genetics | Melanoma, Experimental - therapy | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Melanoma, Experimental - pathology | Membrane Proteins - immunology | Mice, Transgenic | Combined Modality Therapy | T-Box Domain Proteins - genetics | Th2 Cells - metabolism | T-Box Domain Proteins - metabolism | Mice, Knockout | Cell Differentiation - immunology | Oxidoreductases - immunology | Animals | CD4-Positive T-Lymphocytes - transplantation | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Line, Tumor | Mice | Cytotoxicity, Immunologic - immunology
Journal Article
Journal Article
Clinical Immunology, ISSN 1521-6616, 2016, Volume 166-167, pp. 48 - 58
Abstract We designed a phase I trial to investigate the safety, immune responses and clinical benefits of a five-peptide cancer vaccine in combination with... 
Allergy and Immunology | Translational research | Five-peptide cancer vaccine | Cyclophosphamide | Regulatory T cells | INTERLEUKIN-2 | IMMUNE-RESPONSE | LUNG | TESTIS ANTIGENS | IMMUNOLOGY | EPITOPE-PEPTIDES | IDENTIFICATION | BREAST-CANCER | IMMUNOTHERAPY | COLORECTAL-CANCER | REGULATORY T-CELLS | Lung Neoplasms - drug therapy | Cyclophosphamide - administration & dosage | Colorectal Neoplasms - genetics | Humans | Middle Aged | HLA-A24 Antigen - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epitopes - administration & dosage | Male | Cyclophosphamide - adverse effects | Peptides - administration & dosage | Dose-Response Relationship, Drug | Epitopes - immunology | Neoplasms - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Colorectal Neoplasms - drug therapy | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Vaccines, Subunit - adverse effects | Lung Neoplasms - genetics | Stomach Neoplasms - genetics | HLA-A24 Antigen - immunology | Drug Administration Schedule | Cancer Vaccines - administration & dosage | Peptides - immunology | Kaplan-Meier Estimate | Cancer Vaccines - adverse effects | Treatment Outcome | Cyclophosphamide - immunology | Vaccines, Subunit - immunology | Stomach Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - immunology | Neoplasms - drug therapy | Stomach Neoplasms - immunology | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms - immunology | Vaccines, Subunit - administration & dosage | T-Lymphocytes - immunology | Aged | Cancer vaccines | Antigens | Chemotherapy | Peptides | Vaccination | Colorectal cancer | Clinical trials | Product development | T cells | Cancer | Tumors
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 5/2012, Volume 61, Issue 5, pp. 629 - 641
In spite of increased rates of complete response to initial chemotherapy, most patients with advanced ovarian cancer relapse and succumb to progressive... 
Dendritic cell | Immunology | Medicine & Public Health | Cancer Research | Oncology | Clinical trial | Vaccine | Consolidation therapy | Ovarian cancer | SURVIVAL | IMMUNE-RESPONSE | IMMUNOLOGY | PEPTIDE | OVEREXPRESSION | ONCOLOGY | IMMUNOTHERAPY | REGULATORY T-CELLS | HER-2/NEU | CARCINOMA | TUMOR-ASSOCIATED ANTIGEN | LYMPHOCYTES | Dendritic Cells - immunology | Humans | Middle Aged | Monocytes - immunology | Cyclophosphamide - therapeutic use | T-Lymphocytes, Regulatory - immunology | Neoplasm Recurrence, Local - immunology | Young Adult | Cancer Vaccines - therapeutic use | Peptide Fragments - immunology | Malaria Vaccines - immunology | Adult | Female | Bacterial Proteins - immunology | Receptor, ErbB-2 - immunology | Immunotherapy, Adoptive - methods | Neoplasm Recurrence, Local - prevention & control | Neutrophils - immunology | Pneumococcal Vaccines - therapeutic use | Survival Rate | Combined Modality Therapy | Drug Synergism | Cancer Vaccines - immunology | Interferon-gamma - immunology | Adolescent | Ovarian Neoplasms - therapy | Pneumococcal Vaccines - immunology | Ovarian Neoplasms - immunology | Medical colleges | Care and treatment | Peptides | Dendritic cells | Oncology, Experimental | Vaccination | Clinical trials | Research | T cells | Antineoplastic agents | Biometry | Antimitotic agents | Chemotherapy | Cyclophosphamide | Lymphocytes | Analysis | Immunotherapy | Product development | Universities and colleges | Health aspects | Cancer | Index Medicus | Flow cytometry | Cell survival | Intravenous administration | Immunoregulation | Toxicity | Leukocytes (neutrophilic) | Lymphocytes T | Vaccines | Diphtheria | ErbB-2 protein | Immunological tolerance | Immunosuppression | Monocytes | gamma -Interferon | Remission | telomerase reverse transcriptase | Enzyme-linked immunosorbent assay
Journal Article
Breast cancer research : BCR, ISSN 1465-5411, 2014, Volume 16, Issue 1, pp. 488 - 488
Journal Article
European Journal of Immunology, ISSN 0014-2980, 08/2011, Volume 41, Issue 8, pp. 2217 - 2228
In the last two decades, anti‐cancer vaccines have yielded disappointing clinical results despite the fact that high numbers of self/tumor‐specific T cells can... 
Tumor | Lentiviral vector | Immunotherapy | Combination therapies | DENDRITIC CELLS | PROGRAMMED DEATH-1 | MELANOMA PATIENTS | REGULATORY T | IMMUNOLOGY | TUMOR-IMMUNITY | GENETIC IMMUNIZATION | HIV-INFECTION | IN-VIVO | PROSTATE-CANCER | ANTIGEN | Tumor Necrosis Factor-alpha - metabolism | Intramolecular Oxidoreductases - immunology | Lentivirus - immunology | Melanoma, Experimental - drug therapy | Antibodies, Blocking - pharmacology | Green Fluorescent Proteins - genetics | Interferon-gamma - metabolism | Dose-Response Relationship, Drug | Epitopes - immunology | Signal Transduction - immunology | Melanoma, Experimental - immunology | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Tumor Necrosis Factor-alpha - immunology | Lentivirus - genetics | Antineoplastic Agents - pharmacology | Membrane Glycoproteins - immunology | Green Fluorescent Proteins - metabolism | B7-1 Antigen - immunology | B7-H1 Antigen | Immunization - methods | Mice, Inbred C57BL | Peptides - immunology | Genetic Vectors - metabolism | Melanoma, Experimental - pathology | Treatment Outcome | Combined Modality Therapy | Genetic Vectors - genetics | Animals | Signal Transduction - drug effects | Cyclophosphamide - pharmacology | Interferon-gamma - immunology | Antibodies, Blocking - immunology | Cell Line, Tumor | Lymphocyte Count | Programmed Cell Death 1 Receptor | T-Lymphocytes - immunology | Mice | Antigens, Differentiation - immunology | Antigens | Lymphocytes | Chemotherapy
Journal Article
Journal Article
PLoS Pathogens, ISSN 1553-7366, 03/2017, Volume 13, Issue 3, p. e1006250
Currently there are a dozen or so of new vaccine candidates in clinical trials for prevention of tuberculosis (TB) and each formulation attempts to elicit... 
SOLUBLE POLYSACCHARIDES | TUBERCLE-BACILLI | MCE1 OPERON | MICROBIOLOGY | ANTIBODY-MEDIATED IMMUNITY | 1-CYANO-4-DIMETHYLAMINOPYRIDINIUM TETRAFLUOROBORATE | STRUCTURAL FEATURES | MASS-SPECTROMETRY | VIROLOGY | IMMUNOLOGICAL REAGENTS | CRYPTOCOCCUS-NEOFORMANS | MONOCLONAL-ANTIBODIES | PARASITOLOGY | Enzyme-Linked Immunosorbent Assay | Oligonucleotide Array Sequence Analysis | Immunity, Humoral - immunology | Bacterial Toxins - immunology | Mice, Inbred C57BL | Antigens, Bacterial - immunology | Mycobacterium tuberculosis - immunology | Acyltransferases - immunology | Adoptive Transfer | Mannans - immunology | Microscopy, Electron | Tuberculosis - immunology | Vaccines, Conjugate - immunology | Animals | Antibodies, Bacterial - immunology | Female | Bacterial Proteins - immunology | Mice | Tuberculosis Vaccines - immunology | Disease Models, Animal | Prevention | Control | Usage | Polysaccharides | Mycobacterium tuberculosis | Research | Vaccines | Auxotrophy | Colleges & universities | Assaying | pH effects | Antibody response | Fragmentation | Proteins | Alterations | Immunotherapy | Chief executive officers | Public health | Saccharides | Binding | Spleen | Antigens | Pathogens | Construction | Immunization | Crosslinking | Attorneys | Metabolism | Disease control | Survival | Arabinomannan | Authoring | Cyclophosphamide | Chemistry | Tuberculosis | Infectious diseases | Immunogenicity | Monoclonal antibodies | Mass spectrometry | Hygiene | Recognition | Bacilli | Amines | Transcription | Microbiology | Immunoglobulin G | Clinical trials | Antibodies | Infections | Biology | Immunology | pH | Bacteria | Clinical microbiology | Enzyme-linked immunosorbent assay | Dendritic cells | Migraine | Medicine | Lungs | Reagents | Appointments & personnel changes | Microenvironments | Molecular biology | Sexually-transmitted diseases
Journal Article